MedPath

Digital Self-efficacy Training to Bridge Waiting Times for Psychotherapy

Not Applicable
Recruiting
Conditions
Psychiatric Disorder
Waiting for Psychotherapy
Interventions
Behavioral: Digital self-efficacy training
Behavioral: Ecological Momentary Assessment
Registration Number
NCT05560581
Lead Sponsor
Psychiatric University Hospital, Zurich
Brief Summary

The main aim of this project is to improve waiting periods for specialised psychotherapy. We will apply a brief, smartphone-based self-efficacy training to patients with psychiatric disorders waiting for specialised psychotherapy. Additionally, we will use Ecological Momentary Assessment (EMA) to assess mood, social contacts, and other parameters daily. We will investigate whether the training can improve self-efficacy and related constructs and if it can help reduce stress and waitlist drop-outs during waiting periods. Additionally, we will investigate if the self-efficacy training has a positive effect on motivation and therapeutical relationship regarding the subsequent therapy.

After a screening for eligibility, participants will be randomly assigned to intervention and control group. At baseline, participants attend a laboratory session where they are assessed for current psychiatric disorders and further relevant psychological variables. They will then either participate in the digital self-efficacy training combined with EMA (intervention group) or in EMA only (control group). Both will be conducted via a smartphone app. Subsequently, participants will be asked to fill in post questionnaires at three different time points: after having finished app usage, one month later, and after the beginning of the subsequent psychotherapy.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
94
Inclusion Criteria
  • psychiatric disorder
  • age 18-65
  • waiting for psychiatric assessment/treatment (being on waitlist)
  • sufficient knowledge of the German language
  • smartphone user
  • internet access via smartphone
  • internet access at home (laptop, tablet, or computer)
Exclusion Criteria
  • current intense psychotherapy
  • acute suicidality
  • acute psychotic symptoms
  • substance addiction

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupEcological Momentary AssessmentParticipants will receive an one-week digital self-efficacy training (3x/day) and an one-week Ecological Momentary Assessment (3x/day questions on mood, social and virtual contacts).
Intervention groupDigital self-efficacy trainingParticipants will receive an one-week digital self-efficacy training (3x/day) and an one-week Ecological Momentary Assessment (3x/day questions on mood, social and virtual contacts).
Control groupEcological Momentary AssessmentParticipants will receive an one-week Ecological Momentary Assessment (3x/day questions on mood, social and virtual contacts).
Primary Outcome Measures
NameTimeMethod
Change in self-efficacybaseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began

Validated measures ("General Self-Efficacy Scale" (10 items; higher scores indicate higher self-efficacy -\> better outcome), "Coping Self-efficacy scale" (26 items; higher scores indicate higher self-effiacy -\> better outcome) and individual questions based on validated measures assessing specific self-efficacy regarding emotion regulation, therapy and waitlist will be used to assess self-efficacy at baseline and 3 different time points after the intervention.

Secondary Outcome Measures
NameTimeMethod
Change in hopelessnessbaseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began

Hopelessness will be assessed using the validated measure "Beck Hopelessness Scale" (20 items; higher scores indicate greater hopelessness -\> worse outcome).

Change in stressbaseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began

Stress will be assessed using the validated measure "Perceived Stress Scale" (10 items; higher scores indicate greater stress -\> worse outcome).

Change in anxietybaseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began

Anxiety will be assessed using the validated measure "State and Trait Anxiety Scale" (40 items; higher scores indicate greater anxiety -\> worse outcome).

Change in therapy expectationsbaseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began

Therapy expectations will be assessed using the validated measure "Patient Questionnaire on Therapy Expectation and Evaluation" (11 items; higher score indicates higher satisfaction -\> better outcome).

Change in intolerance of uncertaintybaseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began

Intolerance of uncertainty will be assessed using the validated measure "Intolerance of uncertainty scale" (18 items; higher scores indicate greater uncertainty -\> worse outcome).

Change in depressionbaseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began

Depression will be assessed using the validated measure "Beck Depression Inventory II" (21 items; higher scores indicate greater depression -\> worse outcome).

Change in optimismbaseline to 1 day after the intervention, 1 month after the intervention, within 1 month after the subsequent therapy began

Change in life orientation will be assessed using the validated measure "Life Orientation Test Revised" (10 items; higher scores indicate greater optimism -\> better outcome)

Trial Locations

Locations (2)

Psychiatric University Hospital

🇨🇭

Zurich, Switzerland

Integrated Psychiatry Winterthur

🇨🇭

Winterthur, Switzerland

© Copyright 2025. All Rights Reserved by MedPath